CRISPR Therapeutics
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
About
CRISPR Therapeutics is a Swiss-American biotechnology company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines for serious diseases. They develop cures for genetic diseases by precisely modifying DNA, with a diverse portfolio including treatments for hemoglobinopathies, oncology, and regenerative medicine. Their lead program, exagamglogene autotemcel (exa-cel), has received regulatory approval in several countries for sickle cell disease and transfusion-dependent beta thalassemia. Teams look it up for Biotechnology, Gene Editing, Therapeutics.
Frequently asked
What does CRISPR Therapeutics do?
CRISPR Therapeutics is a Biotechnology company that offers Platform. Teams look it up for Gene Editing, Therapeutics, Pharmaceuticals. It is based in Zug, Switzerland and was founded in 2013. Public records show $547M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has CRISPR Therapeutics raised?
CRISPR Therapeutics has raised a total of $547M in funding. The most recent round on record is Series B.
Where is CRISPR Therapeutics headquartered?
CRISPR Therapeutics is headquartered in Zug, Switzerland.
When was CRISPR Therapeutics founded?
CRISPR Therapeutics was founded in 2013.
What industry does CRISPR Therapeutics operate in?
CRISPR Therapeutics operates in Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.